Study | Study location | Study type | Onlay graft donor site | Defect type | Age (years) | Number of patients | Number of implant (patients) | Implant location | Post-loading follow-up | Implant success (%) | Implant survival (%) | Bone Loss from grafted level |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Adell et al. 1990 [24] | Sweden | RS | Iliac | NR | NR | 23 | 124 | Mx | Mean 4.2 years | NR | 73.8 | Mean 1.49mm after 1 year |
Isaksson and Alberius 1992 [23] | Sweden | RS | Iliac | NR | 44–70 | 8 | 46 | Mx | 2.6–5 years | NR | 83% | NR |
Åstrand et al. 1996 [22] | Sweden | RS | Iliac | V and H | 41–70 | 17 | 92 | Mx | 3 years | NR | 75 | Average 2.6mm |
McGrath et al. 1996 [21] | Netherlands | RS | Iliac | V | NR | 18 | 36 | Mn | 1–2.6 years | 91.6 | 100 | 9-10% |
Vermeeren et al. 1996 [32] | Netherlands | RS | Iliac | V | NR | 31 | 78 | Mn | 5 years | NR | 89.7 | 50% |
Steenberghe et al. 1997 [31] | Belgium | RS | Iliac | V and H | 35–68 | 13 | 72 | Mx | 1–10 years | 85 | NR | Average 1.4mm |
Verhoeven et al. 1997 [30] | Netherlands | PS | Iliac | V | 49–78 | 13 | 30 | Mn | Mean 2.4 years | NR | 100 | 36% |
Lekholm et al. 1999 [29] | Scandinavia | RS | Iliac and intra-oral | V and H | NR | 31 | 181 | Mx | 3 years | NR | 76 | NR |
Nyström 2004 [28] | Sweden | RS | Iliac | V and H | 39.4–66.8 | 30 | 177 | Mx | 5–13 years | NR | 5 year: 74.6 10 year: 72.8 | 4.8± 0.13mm |
van der Meij et al. 2005 [27] | Netherlands | RS | Iliac | NR | 37–69 | 17 | 34 | Mn | Mean 4.3 years | 88.2 | 91 | 15% |
Boronat et al. 2010 [26] | Spain | RS | Intra-oral | H | NR | 37 | 73 | Mx and Mn | 1 year | 95.9a | 95.9 | 0.64± NR mm |
Kang et al. 2015 [8] | Korea | RS | Iliac and intra-oral | V and H | 40–72 | 33 | 248 | Mx and Mn | 3 years | NR | 98.38 | 36.4% |
El Zahwy et al. 2019 [25] | Egypt | PS | Chin | V | 24–47 | 8 | 16 | Mx | 6 months | NR | 81.25 | 4.77± 1.67 mm |
Kablan 2020 [20] | Israel | RS | Cranium | V | 20–63 | 11 | 63 | Mn | 2–4.8 years | 100 | 100 | NR |